PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Mar-2026 Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy Businesswire
09-Mar-2026 MaaT Pharma to Present Four Abstracts at the 52nd European Bone Marrow Transplantation Annual Meeting and to Highlight Clinigen-Hosted Industry Symposium on acute GvHD Management Businesswire
09-Mar-2026 Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS Businesswire
09-Mar-2026 CORRECTING and REPLACING QuantHealth Achieves Impressive 8x Financial Growth Across Life Sciences Engagements Businesswire
09-Mar-2026 Medicare's CBD Gamble: Is Washington About to Bypass the FDA Drug Approval System for Marijuana Drugs? ACCESS Newswire
09-Mar-2026 QuantHealth Achieves Impressive 8x Financial Growth Across Life Sciences Engagements Businesswire
09-Mar-2026 AnovoRx Appoints Steve Fitzpatrick as Chief Executive Officer Businesswire
09-Mar-2026 Verily and Samsung Collaborate to Accelerate Clinical Research with the Galaxy Watch and Pre Platform Businesswire
09-Mar-2026 GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists Businesswire
09-Mar-2026 Ampco-Pittsburgh Corporation Announces Significant Increase in Customer Orders Businesswire
09-Mar-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Mar-2026 SignaCor named winner of Discovery Spark programme, receiving £250K from Zinc VC Discovery Park
09-Mar-2026 Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates Businesswire
09-Mar-2026 Update to Faron's Financial Calendar and Date of the Annual General Meeting in 2026 ACCESS Newswire
09-Mar-2026 Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer Businesswire
09-Mar-2026 enGene Reports First Quarter 2026 Financial Results and Provides Business Update Businesswire
09-Mar-2026 Ionis announces changes to Board of Directors Businesswire
09-Mar-2026 Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma Businesswire
09-Mar-2026 Black Book Releases HIMSS26 Floor Guide Grouping Top Client-Rated Exhibitors by Strategic Category ACCESS Newswire
09-Mar-2026 Atamyo Therapeutics Presents Promising Results in the First Patients Treated With Its ATA-200 Gene Therapy in the Clinical Trial Targeting LGMD-R5 Limb-girdle Muscular Dystrophy Businesswire